GoodRx leadership downplays Amazon Pharmacy worries despite lackluster stock price

Money pile and medicine pills representing medical expenses

In a month where GoodRx’s stock has been trading below IPO levels, the startup’s leadership says Amazon Pharmacy still isn’t a threat. Citing third-party data, the company said uptake of Amazon’s pharmacy services have been low, though the retailer still could pose a threat with its growing healthcare business.